We report that A12, an analog peptide of type II collagen, is effective in suppressing autoimmune arthritis in mice bearing a transgene for HLA DRB1*0401.
These experiments represent the first description of analog peptides of type II collagen recognized by T cells in the context of the human DR4 molecule that can suppress autoimmune arthritis.
Our therapy is based on our previous discovery of an analog peptide of type II collagen (CII) that could profoundly suppress arthritis in the CIA model by inducing a unique inhibitory T cell [ 3].
These experiments represent the first description of an analog peptide of type II collagen recognized by T cells in the context of the human DR4 molecule that can suppress autoimmune arthritis, and could become the basis for development of new therapies for RA.
Interestingly, we see a K-theoretic obstruction to the GJS C⁎-algebra analog of Goldman-type theorems for II1-subfactors.
Using a variant of the Multi-Scale Analysis, we prove Anderson localization for generic ensembles in the strong disorder regime and establish an analog of Minami-type bounds for spectral spacings.
This multicenter trial will study both traditional safety and efficacy parameters and the physiologic mechanisms of benefit of the addition to conventional therapy of nesiritide, a recombinant analog of brain-type natriuretic peptide, in this population.
Our therapy is based on our previous discovery of an analog peptide (A9) of type II collagen (CII) with amino acid substitutions made at positions 260 (I to A), 261 (A to B), and 263 (F to N) that could profoundly suppress immunity to CII and arthritis in the collagen-induced arthritis (CIA) model [ 8].
Bisphosphonate substrate analogs of the type that inhibit farnesyl diphosphate synthase (C15) and geranylgeranyl diphosphate synthase (C20) also inhibited the fused geranyl diphosphate synthase, apparently by interacting at both the allylic and homoallylic co-substrate binding sites.
Although other mechanisms of gene regulation between the binary and continuous extremes can be considered, for understanding the organizational principles of transcriptional regulation we assume a working model here in which the impacts of the two distinct logical types of control – one of digital and another of analog type – are to be clearly distinguished and related to each other.
Using (14 - 17 14 - 17e theorem anduthehe discretheoremog of aboutnwall thee integral inequality with two discretet limits [4, 6], we obtanalogx − N + 1 ≤ k ≤ N ∥ A ( u k + u k − 1 ) 2 ∥ H ≤ M ˜ [ ∥ A u 0 ∥ H + ∥ A 1 / 2 u 0 ′ ∥ H + ∥ f 0 ∥ H + ∑ k = − N + 1 N ∥ f k − f k − 1 ∥ H ]. (18).
